Biostock: PHI comments on expansion into veterinary IVF
Phase Holographic Imaging is broadening its focus. The company, which previously operated in regenerative medicine and cell therapy, is now adding the fast-growing field of in vitro fertilization, IVF, for livestock to its pipeline. BioStock contacted CEO Patrik Eschricht to learn more about the decision and what opportunities he sees with the new venture.
Our expansion into veterinary IVF stems from both strategic insight and opportunity. Over the years, PHI has built a unique competence in quantitative phase imaging (QPI) and live-cell analysis – technologies that provide powerful, label-free insights into cell behavior. When evaluating new application areas, we saw that the IVF field, both human and veterinary, could greatly benefit from our ability to monitor cell health, development, and morphology in real time.
Patrik Eschricht, CEO
